Seed Investors & VC Firms in Ireland

39 firms in this list, with a median first check of $540K. 4 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
LI Lightstone Ventures HPCGCICI22 people · Leads rounds	88🔒	Portola Valley	US	Pre-Seed–Late Stage	—	+ Add to CRM
AT Atlantic Bridge Ventures BLECGMHM11 people · Follows rounds	88🔒	Dublin	IE	Seed–Late Stage	$1M – $5M	+ Add to CRM
MO Motive Partners Leads rounds	88🔒	New York	US	Pre-Seed–Late Stage	$1M – $10M	+ Add to CRM
SO SOSV CEMSPWPB8 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Series B	$30K – $550K	+ Add to CRM
FO Fountain Healthcare Partners AKMREPJL6 people · Leads rounds	88🔒	Dublin	IE	Seed–Series B	$10.8M – $16.2M	+ Add to CRM
AT Atomico NZAHBBCB11 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
B2 b2venture FSAGCSGJ11 people	88🔒	Berlin	DE	Pre-Seed–Late Stage	$270K – $5.4M	+ Add to CRM
GI Gilde Healthcare AFEDGPHD11 people	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $32.4M	+ Add to CRM
MA Matterwave Ventures BKCRIKRG10 people	88🔒	Munich	DE	Seed–Series B	$1.1M – $10.8M	+ Add to CRM
SW Swisscom Ventures ASPLSKJM9 people	88🔒	Zürich	CH	Seed–Series B	$1M – $20M	+ Add to CRM
HE HealthCap AVAFBOCK11 people	88🔒	Stockholm	SE	Seed–Series A	—	+ Add to CRM
PA Panakes Partners ABDSFLBC11 people	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
TH The Yield Lab Europe BCPFDBGG8 people	88🔒	Dublin	IE	Seed–Series A	$108K – $2.2M	+ Add to CRM
CR CRH Ventures ADMPBKCF10 people	88🔒	Madrid	US	Seed–Series A	—	+ Add to CRM
SE Seroba Life Sciences AOADBMCS7 people	88🔒	Dublin	IE	Seed–Late Stage	$540K – $7.6M	+ Add to CRM
AC ACT Venture Capital DRJFJOAO6 people	88🔒	Dublin	IE	Seed–Series B	$1.1M – $16.2M	+ Add to CRM
NO No Such Ventures RLAGSHTV6 people	88🔒	Amsterdam	NL	Seed–Series A	$2.2M – $8.6M	+ Add to CRM
QU Quadri Ventures CJERJRAD6 people	88🔒	London	GB	Seed–Series B	$1.5M – $5M	+ Add to CRM
CA Capital-E MWLHPVRJ5 people	88🔒	Antwerp	BE	Seed–Series A	$135K – $5.4M	+ Add to CRM
CL Clay Capital MDMVGCKL5 people	88🔒	—	SG	Seed–Late Stage	$3M – $8M	+ Add to CRM
DE Delta Partners ANAWDBMR5 people	88🔒	Dublin	IE	Seed–Series A	$108K – $3.2M	+ Add to CRM
SU Sure Valley Ventures BKBDGMHM8 people	88🔒	London	IE	Seed–Series B	—	+ Add to CRM
AD AdBio partners AHCBEGAC7 people	88🔒	Paris	ES	Seed–Series A	—	+ Add to CRM
CO Connect Ventures PBRSSTMP4 people	88🔒	London	GB	Seed–Series A	$500K – $5M	+ Add to CRM

Lightstone Ventures

Portola ValleyPre-Seed–Late Stage

HPCGCICI22 people

Atlantic Bridge Ventures

DublinSeed–Late Stage$1M – $5M

BLECGMHM11 people

Motive Partners

New YorkPre-Seed–Late Stage$1M – $10M

SOSV

San FranciscoPre-Seed–Series B$30K – $550K

CEMSPWPB8 people

Fountain Healthcare Partners

DublinSeed–Series B$10.8M – $16.2M

AKMREPJL6 people

Atomico

LondonSeed–Late Stage

NZAHBBCB11 people

b2venture

BerlinPre-Seed–Late Stage$270K – $5.4M

FSAGCSGJ11 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $32.4M

AFEDGPHD11 people

Matterwave Ventures

MunichSeed–Series B$1.1M – $10.8M

BKCRIKRG10 people

Swisscom Ventures

ZürichSeed–Series B$1M – $20M

ASPLSKJM9 people

HealthCap

StockholmSeed–Series A

AVAFBOCK11 people

Panakes Partners

MilanSeed–Late Stage

ABDSFLBC11 people

The Yield Lab Europe

DublinSeed–Series A$108K – $2.2M

BCPFDBGG8 people

CRH Ventures

MadridSeed–Series A

ADMPBKCF10 people

Seroba Life Sciences

DublinSeed–Late Stage$540K – $7.6M

AOADBMCS7 people

ACT Venture Capital

DublinSeed–Series B$1.1M – $16.2M

DRJFJOAO6 people

No Such Ventures

AmsterdamSeed–Series A$2.2M – $8.6M

RLAGSHTV6 people

Quadri Ventures

LondonSeed–Series B$1.5M – $5M

CJERJRAD6 people

Capital-E

AntwerpSeed–Series A$135K – $5.4M

MWLHPVRJ5 people

Clay Capital

Seed–Late Stage$3M – $8M

MDMVGCKL5 people

Delta Partners

DublinSeed–Series A$108K – $3.2M

ANAWDBMR5 people

Sure Valley Ventures

LondonSeed–Series B

BKBDGMHM8 people

AdBio partners

ParisSeed–Series A

AHCBEGAC7 people

Connect Ventures

LondonSeed–Series A$500K – $5M

PBRSSTMP4 people

Data sourced from public filings and firms' own websites — see our methodology.